AU2003255331A8 - Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damage - Google Patents
Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damageInfo
- Publication number
- AU2003255331A8 AU2003255331A8 AU2003255331A AU2003255331A AU2003255331A8 AU 2003255331 A8 AU2003255331 A8 AU 2003255331A8 AU 2003255331 A AU2003255331 A AU 2003255331A AU 2003255331 A AU2003255331 A AU 2003255331A AU 2003255331 A8 AU2003255331 A8 AU 2003255331A8
- Authority
- AU
- Australia
- Prior art keywords
- stimulation
- inhibition
- reduction
- novel compounds
- nerve growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002134697 DE10234697A1 (en) | 2002-07-30 | 2002-07-30 | New compounds to stimulate nerve growth, inhibit scar tissue formation and / or reduce secondary damage |
| DE10234697.6 | 2002-07-30 | ||
| PCT/EP2003/008444 WO2004012649A2 (en) | 2002-07-30 | 2003-07-30 | Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003255331A8 true AU2003255331A8 (en) | 2004-02-23 |
| AU2003255331A1 AU2003255331A1 (en) | 2004-02-23 |
Family
ID=30469198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003255331A Abandoned AU2003255331A1 (en) | 2002-07-30 | 2003-07-30 | Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damage |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003255331A1 (en) |
| DE (1) | DE10234697A1 (en) |
| WO (1) | WO2004012649A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996030534A1 (en) | 1995-03-24 | 1996-10-03 | Genzyme Corporation | Adenovirus vectors for gene therapy |
| US5707618A (en) | 1995-03-24 | 1998-01-13 | Genzyme Corporation | Adenovirus vectors for gene therapy |
| EP2000134A1 (en) * | 2007-06-06 | 2008-12-10 | Neuraxo Biopharmaceuticals GmbH | Use of a substance for the improvement of pns lesions |
-
2002
- 2002-07-30 DE DE2002134697 patent/DE10234697A1/en not_active Withdrawn
-
2003
- 2003-07-30 AU AU2003255331A patent/AU2003255331A1/en not_active Abandoned
- 2003-07-30 WO PCT/EP2003/008444 patent/WO2004012649A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004012649A2 (en) | 2004-02-12 |
| DE10234697A1 (en) | 2004-02-19 |
| AU2003255331A1 (en) | 2004-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003267203A8 (en) | Method for administering thermotherapy to prevent the growth of tumors | |
| IL172047A0 (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| HUP0501069A2 (en) | Quinazoline derivatives for the treatment of abnormal cell growth | |
| EP1539234A4 (en) | Methods of preventing or treating cell malignancies by administering cd2 antagonists | |
| AU2001263447A1 (en) | Stimulation method for the sphenopalatine ganglia, sphenopalatine nerve, or vidian nerve for treatment of medical conditions | |
| AU2003224788A1 (en) | Method for treatment of tissue | |
| AU2431802A (en) | Surgically implanted devices having reduced scar tissue | |
| AU5032500A (en) | Treatment of irregular ventricular contractions | |
| AU2003303287A1 (en) | Method of cardiac risk assessment | |
| EP1553951A4 (en) | Methods of using and compositions comprising a jnk inhibitor for the treatment, prevention, management and/or modification of pain | |
| AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
| WO2002060972A3 (en) | Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof | |
| PL377686A1 (en) | 4-anilino quinazoline derivatives for the treatment of abnormal cell growth | |
| EP1569516A4 (en) | Methods for inhibiting cancer and scar formation | |
| AU2003255331A8 (en) | Novel compounds for stimulation of nerve growth, for the inhibition of scar tissue formation and/or reduction of secondary damage | |
| WO2003037308A3 (en) | Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion | |
| AU2002217149A1 (en) | Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages | |
| AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
| WO2004003152A3 (en) | Sos1 inhibitors | |
| HK1049146A1 (en) | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23. | |
| AU2003287424A8 (en) | Methods of inhibiting glial scar formation | |
| AU1522101A (en) | Heparanase inhibitors for the treatment of heart failure | |
| AU2002350666A1 (en) | Utilization of inhibitors of Rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion | |
| AU2003252185A8 (en) | Topical composition for the treatment of scar tissue | |
| AU2003269985A1 (en) | Methods for increasing the rate of heart muscle contraction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |